Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04688801
What this trial is testing

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Who this might be right for
Esophageal CancerGastroesophageal CancerImmunotherapy+1 more
The Second Hospital of Shandong University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06313190
What this trial is testing

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 140
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT01894373
What this trial is testing

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Who this might be right for
PsoriasisAdoptive Immunotherapy
Chinese PLA General Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT05987241
What this trial is testing

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial Carcinoma+4 more
National Cancer Institute (NCI)
Not applicableUnknownNCT06472635
What this trial is testing

A Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study

Who this might be right for
The Neoadjuvant Treatment for Resectable Esophageal Squamous Cell Carcinoma
Zhejiang University 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT02649582
What this trial is testing

Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital, Antwerp 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07645118
What this trial is testing

Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Dr. Te Vuong 10
Testing effectiveness (Phase 2)Study completedNCT00118625
What this trial is testing

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT00986518
What this trial is testing

T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 5
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Early research (Phase 1)Looking for participantsNCT05984342
What this trial is testing

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Cancer Hospital of Shantou University Medical College 50
Testing effectiveness (Phase 2)UnknownNCT04333927
What this trial is testing

Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer

Who this might be right for
Biliary Tract CancerExtrahepatic CholangiocarcinomaGallbladder Cancer
Sun Yat-sen University 92
Not applicableStudy completedNCT05611229
What this trial is testing

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

Who this might be right for
Metastatic Melanoma
Novartis Pharmaceuticals 1,975
Testing effectiveness (Phase 2)Study completedNCT05239169
What this trial is testing

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (CCA)Intrahepatic CholangiocarcinomaHilar Cholangiocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Looking for participantsNCT04109755
What this trial is testing

Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer

Who this might be right for
Rectum CancerRectal Cancer
University Hospital, Geneva 25
Large-scale testing (Phase 3)Looking for participantsNCT07720284
What this trial is testing

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Who this might be right for
High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca 915
Testing effectiveness (Phase 2)Ended earlyNCT03630640
What this trial is testing

Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation

Who this might be right for
Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 43
Testing effectiveness (Phase 2)Study completedNCT03559413
What this trial is testing

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Who this might be right for
Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults
University Children's Hospital Tuebingen 30
Next Page
992